2023
Extended law of laplace for measurement of the cloverleaf anatomy of the aortic root
Ban E, Kalogerakos P, Khosravi R, Ziganshin B, Ellauzi H, Ramachandra A, Zafar M, Humphrey J, Elefteriades J. Extended law of laplace for measurement of the cloverleaf anatomy of the aortic root. The International Journal Of Cardiovascular Imaging 2023, 39: 1345-1356. PMID: 37046157, PMCID: PMC10250276, DOI: 10.1007/s10554-023-02847-5.Peer-Reviewed Original ResearchMeSH KeywordsAortaAorta, ThoracicAortic ValveBicuspid Aortic Valve DiseaseBlood PressureHumansPredictive Value of TestsConceptsAortic root
2020
Essential information on surgical heart valve characteristics for optimal valve prosthesis selection: Expert consensus document from the European Association for Cardio-Thoracic Surgery (EACTS)–The Society of Thoracic Surgeons (STS)–American Association for Thoracic Surgery (AATS) Valve Labelling Task Force
Durko AP, Pibarot P, Atluri P, Bapat V, Cameron D, Casselman FPA, Chen EP, Dahle G, Elefteriades JA, Lancellotti P, Prager RL, Rosenhek R, Speir A, Stijnen M, Tasca G, Yoganathan A, Walther T, De Paulis R, Force E, De Paulis R, Atluri P, Bapat V, Cameron D, Casselman F, Chen E, Dahle G, Durko A, Elefteriades J, Prager R, Speir A, Tasca G, Lancellotti P, Pibarot P, Rosenhek R, de Hart J, Stijnen M, Yoganathan A, Ibrahim N, Laschinger J, Wu C, Di Rienzo G, McLaren A, Randall H, Becker L, Capps S, Duncan B, Green C, Hay J, Head S, Ieropoli O, Jacob A, Kappetein A, Manasse E, Marquez S, Northrup W, Ryan T, Smith W. Essential information on surgical heart valve characteristics for optimal valve prosthesis selection: Expert consensus document from the European Association for Cardio-Thoracic Surgery (EACTS)–The Society of Thoracic Surgeons (STS)–American Association for Thoracic Surgery (AATS) Valve Labelling Task Force. Journal Of Thoracic And Cardiovascular Surgery 2020, 161: 545-558. PMID: 33070936, DOI: 10.1016/j.jtcvs.2020.10.001.Peer-Reviewed Original Research
2016
Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors
Kleiman N, Maini B, Reardon M, Conte J, Katz S, Rajagopal V, Kauten J, Hartman A, McKay R, Hagberg R, Huang J, Popma J, Adams D, Ad N, Aharonian V, Anderson W, Applegate R, Bafi A, Bajwa T, Bakhos M, Ball S, Batra S, Beohar N, Brachinsky W, Brinster D, Brown J, Byrne J, Byrne T, Casale A, Caskey M, Chawla A, Cohen H, Coselli J, Costa M, Cheatham J, Chetcuti S, Crestanello J, Davis T, Michael Deeb G, Diez J, Dauerman H, Elefteriades J, Fail P, Feinberg E, Fontana G, Forrest J, Galloway A, Giacomini J, Gleason T, Guadiani V, Harrison J, Hebeler R, Heimansohn D, Heiser J, Heller L, Henry S, Hermiller J, Hockmuth D, Hughes G, Joye J, Kafi A, Kar B, Khabbaz K, Kipperman R, Kliger C, Kon N, Lamelas J, Lee J, Leya F, Londono J, Macheers S, Mangi A, de Marchena E, Markowitz A, Matthews R, Merhi W, Mumtaz M, O’Hair D, Petrossian G, Pfeffer T, Raybuck B, Resar J, Robbins M, Robbins R, Robinson N, Ring M, Salerno T, Schreiber T, Schmoker J, Sharma S, Siwek L, Skelding K, Slater J, Starnes V, Stoler R, Subramanian V, Tadros P, Thompson C, Waksman R, Watson D, Yakubov S, Zhao D, Zorn G. Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors. Circulation Cardiovascular Interventions 2016, 9: e003551. PMID: 27601429, DOI: 10.1161/circinterventions.115.003551.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAortic ValveAortic Valve StenosisBalloon ValvuloplastyBioprosthesisCalcinosisCardiac Pacing, ArtificialClinical Trials as TopicFemaleHeart Valve ProsthesisHumansIncidenceIntracranial EmbolismKaplan-Meier EstimateMaleProportional Hazards ModelsRisk AssessmentRisk FactorsSeverity of Illness IndexStrokeTime FactorsTranscatheter Aortic Valve ReplacementTreatment OutcomeConceptsTranscatheter aortic valve replacementAortic valve replacementValve replacementEarly strokePrior coronary artery bypass surgeryHealth Stroke Scale scoreSelf-expanding CoreValve bioprosthesisCoronary artery bypass surgerySmaller body surface areaLower body mass indexContinued Access StudySevere aortic calcificationStroke Scale scoreTransient ischemic attackArtery bypass surgeryPeripheral vascular diseasePredictors of strokeBody mass indexBody surface areaIdentification of predictorsCoreValve bioprosthesisIschemic attackPrior strokeBypass surgeryAortic calcification
1995
Valve Replacement for Regurgitant Lesions of the Aortic or Mitral Valve in Advanced Left Ventricular Dysfunction
Bonow R, Nikas D, Elefteriades J. Valve Replacement for Regurgitant Lesions of the Aortic or Mitral Valve in Advanced Left Ventricular Dysfunction. Cardiology Clinics 1995, 13: 73-83. PMID: 7796434, DOI: 10.1016/s0733-8651(18)30063-8.Peer-Reviewed Original ResearchConceptsLeft ventricular dysfunctionAdvanced left ventricular dysfunctionSevere left ventricular dysfunctionVentricular dysfunctionValve replacementLate left ventricular dysfunctionSubvalvular mitral apparatusSevere systolic dysfunctionAortic valve replacementCongestive heart failureMitral valve repairRegurgitant valvular lesionsSystolic dysfunctionAortic regurgitationSystolic functionHeart failureValvular lesionsCardiology clinicMitral regurgitationValve repairSevere depressionMitral valveMitral apparatusPatient's familyAlternative treatment
1992
Transesophageal echocardiographic evaluation of aortic valve integrity with antegrade crystalloid cardioplegic solution used as an imaging agent
Rafferty T, Durkin M, Elefteriades J, O’Connor T. Transesophageal echocardiographic evaluation of aortic valve integrity with antegrade crystalloid cardioplegic solution used as an imaging agent. Journal Of Thoracic And Cardiovascular Surgery 1992, 104: 637-641. PMID: 1513154, DOI: 10.1016/s0022-5223(19)34729-4.Peer-Reviewed Original ResearchConceptsCrystalloid cardioplegic solutionCardioplegic solutionValve dysfunctionValve integrityEchocardiographic contrast agentsImaging agentVentricular dimensional changesAortic regurgitationEchocardiographic evaluationLeft atriumCardiac dimensionsIntravascular injectionSolution administrationPatientsDysfunctionContrast agentsAgentsEchocardiographyRegurgitationAtriumAdministration
1989
Mild mitral insufficiency is a marker of impaired left ventricular performance in aortic stenosis
Schulman D, Remetz M, Elefteriades J, Frances C. Mild mitral insufficiency is a marker of impaired left ventricular performance in aortic stenosis. Journal Of The American College Of Cardiology 1989, 13: 796-801. PMID: 2926033, DOI: 10.1016/0735-1097(89)90218-0.Peer-Reviewed Original ResearchConceptsAortic stenosisEjection fractionGroup 2Mitral insufficiencyGroup 1Ventricular performanceEnd-systolic volume index ratioControl groupEnd-systolic volume indexSignificant coronary artery diseaseEnd-systolic wall stressImpaired left ventricular performanceGroup 2 patientsMild mitral insufficiencyPure aortic stenosisAortic valve replacementAortic valve areaCoronary artery diseaseLeft ventricular functionEnd-systolic stressLeft ventricular performanceWall stressCardiac indexValve replacementArtery disease
1987
Long-term performance of the St. Jude Medical valve: low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin.
Kopf G, Hammond G, Geha A, Elefteriades J, Hashim S. Long-term performance of the St. Jude Medical valve: low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin. Circulation 1987, 76: iii132-6. PMID: 3621536.Peer-Reviewed Original ResearchConceptsSt. Jude Medical valveJude Medical valveModest dosesHemorrhagic complicationsLower incidenceValve failureLate cardiac deathStructural valve failureDouble valve replacementPercent of patientsOccurrence of thromboembolismHospital survivorsAnticoagulation regimenPerivalvular leakValve thrombosisValve replacementCardiac deathProthrombin timeMitral positionThromboembolismPatientsComplicationsThrombosisWarfarinIncidence